nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—Dacarbazine—muscle cancer	0.314	0.362	CbGbCtD
Alosetron—CYP1A2—Dacarbazine—muscle cancer	0.181	0.209	CbGbCtD
Alosetron—CYP2E1—Etoposide—muscle cancer	0.154	0.177	CbGbCtD
Alosetron—CYP1A2—Etoposide—muscle cancer	0.0888	0.102	CbGbCtD
Alosetron—CYP3A4—Vincristine—muscle cancer	0.0508	0.0586	CbGbCtD
Alosetron—CYP3A4—Etoposide—muscle cancer	0.0465	0.0537	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—muscle cancer	0.0317	0.0366	CbGbCtD
Alosetron—Proctitis—Dactinomycin—muscle cancer	0.00911	0.0683	CcSEcCtD
Alosetron—Tachyarrhythmia—Doxorubicin—muscle cancer	0.00457	0.0343	CcSEcCtD
Alosetron—Folliculitis—Dactinomycin—muscle cancer	0.00354	0.0265	CcSEcCtD
Alosetron—Proctitis—Doxorubicin—muscle cancer	0.00342	0.0257	CcSEcCtD
Alosetron—Ileus—Vincristine—muscle cancer	0.00281	0.0211	CcSEcCtD
Alosetron—Nail disorder—Etoposide—muscle cancer	0.00248	0.0186	CcSEcCtD
Alosetron—Ulcer—Dactinomycin—muscle cancer	0.00235	0.0176	CcSEcCtD
Alosetron—Cognitive disorder—Methotrexate—muscle cancer	0.00223	0.0167	CcSEcCtD
Alosetron—Drug interaction—Vincristine—muscle cancer	0.00214	0.0161	CcSEcCtD
Alosetron—Bone pain—Vincristine—muscle cancer	0.00208	0.0156	CcSEcCtD
Alosetron—Urine output increased—Vincristine—muscle cancer	0.0018	0.0135	CcSEcCtD
Alosetron—Ulcer—Etoposide—muscle cancer	0.0017	0.0128	CcSEcCtD
Alosetron—Polyuria—Vincristine—muscle cancer	0.00164	0.0123	CcSEcCtD
Alosetron—Folliculitis—Methotrexate—muscle cancer	0.00153	0.0115	CcSEcCtD
Alosetron—Nail disorder—Methotrexate—muscle cancer	0.00149	0.0112	CcSEcCtD
Alosetron—Burning sensation—Methotrexate—muscle cancer	0.00139	0.0104	CcSEcCtD
Alosetron—Folliculitis—Doxorubicin—muscle cancer	0.00133	0.00997	CcSEcCtD
Alosetron—Nail disorder—Doxorubicin—muscle cancer	0.00129	0.00966	CcSEcCtD
Alosetron—Fungal infection—Methotrexate—muscle cancer	0.00125	0.00937	CcSEcCtD
Alosetron—Burning sensation—Doxorubicin—muscle cancer	0.0012	0.00902	CcSEcCtD
Alosetron—Ileus—Doxorubicin—muscle cancer	0.00118	0.00885	CcSEcCtD
Alosetron—Laryngitis—Doxorubicin—muscle cancer	0.00116	0.00869	CcSEcCtD
Alosetron—Dermatitis atopic—Doxorubicin—muscle cancer	0.00113	0.00846	CcSEcCtD
Alosetron—Hepatitis—Dactinomycin—muscle cancer	0.00112	0.00838	CcSEcCtD
Alosetron—Depression—Vincristine—muscle cancer	0.00111	0.00832	CcSEcCtD
Alosetron—Fungal infection—Doxorubicin—muscle cancer	0.00108	0.00811	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.00108	0.00806	CcSEcCtD
Alosetron—Sweating—Vincristine—muscle cancer	0.00107	0.008	CcSEcCtD
Alosetron—Cramp muscle—Etoposide—muscle cancer	0.00105	0.00789	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00103	0.00773	CcSEcCtD
Alosetron—Ulcer—Methotrexate—muscle cancer	0.00102	0.00765	CcSEcCtD
Alosetron—Hypoaesthesia—Vincristine—muscle cancer	0.000993	0.00745	CcSEcCtD
Alosetron—Alopecia—Dactinomycin—muscle cancer	0.000987	0.0074	CcSEcCtD
Alosetron—Cystitis noninfective—Methotrexate—muscle cancer	0.000942	0.00707	CcSEcCtD
Alosetron—Cystitis—Methotrexate—muscle cancer	0.000931	0.00699	CcSEcCtD
Alosetron—Ill-defined disorder—Dactinomycin—muscle cancer	0.000902	0.00677	CcSEcCtD
Alosetron—Ulcer—Doxorubicin—muscle cancer	0.000883	0.00662	CcSEcCtD
Alosetron—Alopecia—Vincristine—muscle cancer	0.000882	0.00662	CcSEcCtD
Alosetron—Jaundice—Etoposide—muscle cancer	0.000878	0.00659	CcSEcCtD
Alosetron—Malaise—Dactinomycin—muscle cancer	0.000877	0.00658	CcSEcCtD
Alosetron—Urine output increased—Methotrexate—muscle cancer	0.000872	0.00654	CcSEcCtD
Alosetron—Bladder pain—Methotrexate—muscle cancer	0.000872	0.00654	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—muscle cancer	0.000872	0.00654	CcSEcCtD
Alosetron—Myalgia—Dactinomycin—muscle cancer	0.000828	0.00621	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—muscle cancer	0.000825	0.00619	CcSEcCtD
Alosetron—Discomfort—Dactinomycin—muscle cancer	0.000818	0.00614	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—muscle cancer	0.000816	0.00612	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—muscle cancer	0.000806	0.00605	CcSEcCtD
Alosetron—Hypoaesthesia—Etoposide—muscle cancer	0.000805	0.00603	CcSEcCtD
Alosetron—Colitis—Doxorubicin—muscle cancer	0.000802	0.00601	CcSEcCtD
Alosetron—Polyuria—Methotrexate—muscle cancer	0.000797	0.00598	CcSEcCtD
Alosetron—Infection—Dactinomycin—muscle cancer	0.000789	0.00591	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—muscle cancer	0.000755	0.00566	CcSEcCtD
Alosetron—Hypertension—Vincristine—muscle cancer	0.00075	0.00563	CcSEcCtD
Alosetron—Myalgia—Vincristine—muscle cancer	0.00074	0.00555	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000723	0.00542	CcSEcCtD
Alosetron—Alopecia—Etoposide—muscle cancer	0.000715	0.00536	CcSEcCtD
Alosetron—Infection—Vincristine—muscle cancer	0.000705	0.00528	CcSEcCtD
Alosetron—Hyperhidrosis—Vincristine—muscle cancer	0.000686	0.00514	CcSEcCtD
Alosetron—Fatigue—Dactinomycin—muscle cancer	0.000684	0.00513	CcSEcCtD
Alosetron—Pain—Dactinomycin—muscle cancer	0.000679	0.00509	CcSEcCtD
Alosetron—Muscle spasms—Etoposide—muscle cancer	0.000677	0.00508	CcSEcCtD
Alosetron—Eczema—Doxorubicin—muscle cancer	0.000675	0.00506	CcSEcCtD
Alosetron—Feeling abnormal—Dactinomycin—muscle cancer	0.000654	0.00491	CcSEcCtD
Alosetron—Ill-defined disorder—Etoposide—muscle cancer	0.000653	0.0049	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000646	0.00485	CcSEcCtD
Alosetron—Malaise—Etoposide—muscle cancer	0.000635	0.00476	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—muscle cancer	0.000621	0.00466	CcSEcCtD
Alosetron—Cough—Etoposide—muscle cancer	0.000614	0.00461	CcSEcCtD
Alosetron—Fatigue—Vincristine—muscle cancer	0.000611	0.00459	CcSEcCtD
Alosetron—Hypertension—Etoposide—muscle cancer	0.000608	0.00456	CcSEcCtD
Alosetron—Pain—Vincristine—muscle cancer	0.000606	0.00455	CcSEcCtD
Alosetron—Constipation—Vincristine—muscle cancer	0.000606	0.00455	CcSEcCtD
Alosetron—Discomfort—Etoposide—muscle cancer	0.000592	0.00444	CcSEcCtD
Alosetron—Hypersensitivity—Dactinomycin—muscle cancer	0.000585	0.00439	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—muscle cancer	0.00058	0.00435	CcSEcCtD
Alosetron—Confusional state—Etoposide—muscle cancer	0.000579	0.00434	CcSEcCtD
Alosetron—Infection—Etoposide—muscle cancer	0.000571	0.00428	CcSEcCtD
Alosetron—Asthenia—Dactinomycin—muscle cancer	0.00057	0.00427	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000562	0.00422	CcSEcCtD
Alosetron—Skin disorder—Etoposide—muscle cancer	0.000558	0.00419	CcSEcCtD
Alosetron—Hyperhidrosis—Etoposide—muscle cancer	0.000555	0.00417	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—muscle cancer	0.000554	0.00415	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—muscle cancer	0.000542	0.00407	CcSEcCtD
Alosetron—Depression—Methotrexate—muscle cancer	0.000538	0.00403	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—muscle cancer	0.000537	0.00402	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000535	0.00401	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—muscle cancer	0.000528	0.00396	CcSEcCtD
Alosetron—Hypersensitivity—Vincristine—muscle cancer	0.000523	0.00392	CcSEcCtD
Alosetron—Sweating—Methotrexate—muscle cancer	0.000517	0.00388	CcSEcCtD
Alosetron—Asthenia—Vincristine—muscle cancer	0.000509	0.00382	CcSEcCtD
Alosetron—Vomiting—Dactinomycin—muscle cancer	0.000505	0.00379	CcSEcCtD
Alosetron—Rash—Dactinomycin—muscle cancer	0.000501	0.00375	CcSEcCtD
Alosetron—Fatigue—Etoposide—muscle cancer	0.000495	0.00371	CcSEcCtD
Alosetron—Constipation—Etoposide—muscle cancer	0.000491	0.00368	CcSEcCtD
Alosetron—Pain—Etoposide—muscle cancer	0.000491	0.00368	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000487	0.00365	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—muscle cancer	0.000487	0.00365	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—muscle cancer	0.000484	0.00363	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—muscle cancer	0.000484	0.00363	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—muscle cancer	0.000484	0.00363	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—muscle cancer	0.000473	0.00355	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—muscle cancer	0.000473	0.00354	CcSEcCtD
Alosetron—Nausea—Dactinomycin—muscle cancer	0.000472	0.00354	CcSEcCtD
Alosetron—Urticaria—Etoposide—muscle cancer	0.000456	0.00342	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—muscle cancer	0.000455	0.00342	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—muscle cancer	0.000454	0.00341	CcSEcCtD
Alosetron—Vomiting—Vincristine—muscle cancer	0.000451	0.00338	CcSEcCtD
Alosetron—Sweating—Doxorubicin—muscle cancer	0.000448	0.00336	CcSEcCtD
Alosetron—Rash—Vincristine—muscle cancer	0.000447	0.00335	CcSEcCtD
Alosetron—Dermatitis—Vincristine—muscle cancer	0.000447	0.00335	CcSEcCtD
Alosetron—Headache—Vincristine—muscle cancer	0.000444	0.00333	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—muscle cancer	0.000438	0.00329	CcSEcCtD
Alosetron—Alopecia—Methotrexate—muscle cancer	0.000428	0.00321	CcSEcCtD
Alosetron—Hypersensitivity—Etoposide—muscle cancer	0.000423	0.00317	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—muscle cancer	0.000422	0.00316	CcSEcCtD
Alosetron—Nausea—Vincristine—muscle cancer	0.000421	0.00316	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—muscle cancer	0.000419	0.00315	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—muscle cancer	0.000419	0.00315	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—muscle cancer	0.000417	0.00313	CcSEcCtD
Alosetron—Asthenia—Etoposide—muscle cancer	0.000412	0.00309	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—muscle cancer	0.000391	0.00293	CcSEcCtD
Alosetron—Malaise—Methotrexate—muscle cancer	0.00038	0.00285	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—muscle cancer	0.000375	0.00281	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—muscle cancer	0.000371	0.00278	CcSEcCtD
Alosetron—Cough—Methotrexate—muscle cancer	0.000368	0.00276	CcSEcCtD
Alosetron—Vomiting—Etoposide—muscle cancer	0.000365	0.00274	CcSEcCtD
Alosetron—Rash—Etoposide—muscle cancer	0.000362	0.00272	CcSEcCtD
Alosetron—Dermatitis—Etoposide—muscle cancer	0.000362	0.00271	CcSEcCtD
Alosetron—Headache—Etoposide—muscle cancer	0.00036	0.0027	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—muscle cancer	0.00036	0.0027	CcSEcCtD
Alosetron—Myalgia—Methotrexate—muscle cancer	0.000359	0.00269	CcSEcCtD
Alosetron—Discomfort—Methotrexate—muscle cancer	0.000355	0.00266	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—muscle cancer	0.000351	0.00263	CcSEcCtD
Alosetron—Confusional state—Methotrexate—muscle cancer	0.000347	0.0026	CcSEcCtD
Alosetron—Infection—Methotrexate—muscle cancer	0.000342	0.00256	CcSEcCtD
Alosetron—Nausea—Etoposide—muscle cancer	0.000341	0.00256	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—muscle cancer	0.000339	0.00254	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—muscle cancer	0.000334	0.00251	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—muscle cancer	0.000333	0.00249	CcSEcCtD
Alosetron—Malaise—Doxorubicin—muscle cancer	0.000329	0.00247	CcSEcCtD
Alosetron—Cough—Doxorubicin—muscle cancer	0.000319	0.00239	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—muscle cancer	0.000315	0.00236	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000314	0.00235	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—muscle cancer	0.000311	0.00233	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—muscle cancer	0.00031	0.00232	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—muscle cancer	0.000307	0.0023	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—muscle cancer	0.000304	0.00228	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—muscle cancer	0.0003	0.00225	CcSEcCtD
Alosetron—Fatigue—Methotrexate—muscle cancer	0.000297	0.00223	CcSEcCtD
Alosetron—Infection—Doxorubicin—muscle cancer	0.000296	0.00222	CcSEcCtD
Alosetron—Pain—Methotrexate—muscle cancer	0.000294	0.00221	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—muscle cancer	0.000289	0.00217	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—muscle cancer	0.000288	0.00216	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—muscle cancer	0.000284	0.00213	CcSEcCtD
Alosetron—Urticaria—Methotrexate—muscle cancer	0.000273	0.00205	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000271	0.00204	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—muscle cancer	0.000257	0.00193	CcSEcCtD
Alosetron—Constipation—Doxorubicin—muscle cancer	0.000255	0.00191	CcSEcCtD
Alosetron—Pain—Doxorubicin—muscle cancer	0.000255	0.00191	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—muscle cancer	0.000254	0.0019	CcSEcCtD
Alosetron—Asthenia—Methotrexate—muscle cancer	0.000247	0.00185	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—muscle cancer	0.000246	0.00184	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—muscle cancer	0.000237	0.00178	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—muscle cancer	0.00022	0.00165	CcSEcCtD
Alosetron—Vomiting—Methotrexate—muscle cancer	0.000219	0.00164	CcSEcCtD
Alosetron—Rash—Methotrexate—muscle cancer	0.000217	0.00163	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—muscle cancer	0.000217	0.00163	CcSEcCtD
Alosetron—Headache—Methotrexate—muscle cancer	0.000216	0.00162	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—muscle cancer	0.000214	0.0016	CcSEcCtD
Alosetron—Nausea—Methotrexate—muscle cancer	0.000204	0.00153	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—muscle cancer	0.000189	0.00142	CcSEcCtD
Alosetron—Rash—Doxorubicin—muscle cancer	0.000188	0.00141	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—muscle cancer	0.000188	0.00141	CcSEcCtD
Alosetron—Headache—Doxorubicin—muscle cancer	0.000187	0.0014	CcSEcCtD
Alosetron—Nausea—Doxorubicin—muscle cancer	0.000177	0.00133	CcSEcCtD
